SEGMENTS (Details)	3 Months Ended						9 Months Ended
	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Sep. 30, 2023 USD ($) Facility	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Segment Reporting Information [Abstract]
Number of FDA-licensed plasma collection facilities | Facility							9
Number of remaining plasma collection facilities under construction | Facility							10
Revenues	$ 67,274,598			$ 41,090,137			$ 184,311,323	$ 104,098,237
Cost of product revenue	42,622,013			31,433,496			126,455,745	83,010,156
Income (loss) from operations	8,685,159			(9,316,733)			7,398,764	(33,306,538)
Interest and other expense, net	(6,120,104)			(5,582,771)			(17,993,231)	(13,695,788)
Loss on extinguishment of debt	0			0			0	(6,669,941)
Net income (loss)	2,565,055	$ (6,370,707)	$ (6,788,815)	(14,899,504)	$ (13,764,906)	$ (25,007,857)	(10,594,467)	(53,672,267)
Capital expenditures							3,573,786	10,162,650
Total assets	348,996,565			300,557,570			348,996,565	300,557,570	$ 348,461,881
Depreciation and amortization expense	2,092,508			1,861,992			6,223,050	5,176,492
United States [Member]
Segment Reporting Information [Abstract]
Revenues	64,617,747			37,854,167			173,920,284	96,445,162
International [Member]
Segment Reporting Information [Abstract]
Revenues	2,656,851			3,235,970			10,391,039	7,653,075
Corporate [Member]
Segment Reporting Information [Abstract]
Revenues	35,708			35,708			107,125	107,125
Cost of product revenue	0			0			0	0
Income (loss) from operations	(5,648,769)			(4,977,774)			(16,149,421)	(16,363,147)
Interest and other expense, net	(5,979,035)			(5,579,594)			(17,822,557)	(13,624,483)
Loss on extinguishment of debt								(6,669,941)
Net income (loss)	(11,627,804)			(10,557,368)			(33,971,978)	(36,657,571)
Capital expenditures							0	0
Total assets	50,821,489			18,448,139			50,821,489	18,448,139
Depreciation and amortization expense	0			0			0	918
Operating Segments [Member] | ADMA BioManufacturing [Member]
Segment Reporting Information [Abstract]
Revenues	66,566,884			37,280,798			175,904,955	95,129,542
Cost of product revenue	41,733,958			27,883,046			118,708,495	74,383,948
Income (loss) from operations	15,016,875			297,310			26,576,977	(4,423,228)
Interest and other expense, net	(140,669)			(3,023)			(170,069)	(70,084)
Loss on extinguishment of debt								0
Net income (loss)	14,876,206			294,287			26,406,908	(4,493,312)
Capital expenditures							1,767,825	4,292,246
Total assets	262,553,540			242,983,498			262,553,540	242,983,498
Depreciation and amortization expense	1,282,076			1,214,529			3,857,085	3,486,212
Operating Segments [Member] | Plasma Collection Centers [Member]
Segment Reporting Information [Abstract]
Revenues	672,006			3,773,631			8,299,243	8,861,570
Cost of product revenue	888,055			3,550,450			7,747,250	8,626,208
Income (loss) from operations	(682,947)			(4,636,269)			(3,028,792)	(12,520,163)
Interest and other expense, net	(400)			(154)			(605)	(1,221)
Loss on extinguishment of debt								0
Net income (loss)	(683,347)			(4,636,423)			(3,029,397)	(12,521,384)
Capital expenditures							1,805,961	5,870,404
Total assets	35,621,536			39,125,933			35,621,536	39,125,933
Depreciation and amortization expense	$ 810,432			$ 647,463			$ 2,365,965	$ 1,689,362